Zenas Biopharma Inc (ZBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -80,987 | -377,737 | -137,295 | -85,796 | -33,573 |
| Depreciation Amortization | 6 | 56 | 46 | 35 | 23 |
| Accounts payable and accrued liabilities | 1,795 | -10,043 | -11,159 | -9,205 | 2,882 |
| Other Working Capital | -9,861 | 951 | -7,364 | -3,700 | -8,858 |
| Other Operating Activity | 13,851 | 214,440 | 35,853 | 19,872 | 2,475 |
| Operating Cash Flow | $-75,196 | $-172,333 | $-119,919 | $-78,794 | $-37,051 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 31,613 | -216,868 | -153,504 | -198,547 | -86,256 |
| PPE Investments | -2 | -18 | -18 | -18 | -18 |
| Net Acquisitions | N/A | -35,000 | -5,000 | N/A | N/A |
| Investing Cash Flow | $31,611 | $-251,886 | $-158,522 | $-198,565 | $-86,274 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 267,500 | 75,000 | 75,000 | N/A | N/A |
| Common Stock Issued | 166,491 | 152,945 | 2,761 | 1,821 | 99 |
| Other Financing Activity | -512 | -12,665 | -3,324 | 0 | 0 |
| Financing Cash Flow | $433,479 | $215,280 | $74,437 | $1,821 | $99 |
| Exchange Rate Effect | -311 | -252 | -263 | -288 | -52 |
| Beginning Cash Position | 110,641 | 319,832 | 319,832 | 319,832 | 319,832 |
| End Cash Position | 500,224 | 110,641 | 115,565 | 44,006 | 196,554 |
| Net Cash Flow | $389,583 | $-209,191 | $-204,267 | $-275,826 | $-123,278 |
| Free Cash Flow | |||||
| Operating Cash Flow | -75,196 | -172,333 | -119,919 | -78,794 | -37,051 |
| Capital Expenditure | -2 | -18 | -18 | -18 | -18 |
| Free Cash Flow | -75,198 | -172,351 | -119,937 | -78,812 | -37,069 |